HARVARD BIOSCIENCE INC — Director's Dealing 2022

Jan 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2022-01-01

Reporting Person: Loewald Thomas W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-01	Common Stock	A	2525	$0.00	Acquired	185626	Direct

Footnotes

F1: Represents an award of 2,525 restricted stock units that will vest in full on the date of the Issuer's 2022 Annual Meeting of the Stockholders.

F2: Includes (a) the award described in footnote (1) above, (b) an award of 14,400 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2021, immediately prior to the commencement of such meeting, and (ii) May 25, 2022, and (c) 168,701 shares of common stock held by the Reporting Person.